Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, China.
State Key Lab of CAD&CG, Zhejiang University, Hangzhou 310058, Zhejiang, China.
Nucleic Acids Res. 2021 Jan 8;49(D1):D1122-D1129. doi: 10.1093/nar/gkaa876.
Inhibitors that form covalent bonds with their targets have traditionally been considered highly adventurous due to their potential off-target effects and toxicity concerns. However, with the clinical validation and approval of many covalent inhibitors during the past decade, design and discovery of novel covalent inhibitors have attracted increasing attention. A large amount of scattered experimental data for covalent inhibitors have been reported, but a resource by integrating the experimental information for covalent inhibitor discovery is still lacking. In this study, we presented Covalent Inhibitor Database (CovalentInDB), the largest online database that provides the structural information and experimental data for covalent inhibitors. CovalentInDB contains 4511 covalent inhibitors (including 68 approved drugs) with 57 different reactive warheads for 280 protein targets. The crystal structures of some of the proteins bound with a covalent inhibitor are provided to visualize the protein-ligand interactions around the binding site. Each covalent inhibitor is annotated with the structure, warhead, experimental bioactivity, physicochemical properties, etc. Moreover, CovalentInDB provides the covalent reaction mechanism and the corresponding experimental verification methods for each inhibitor towards its target. High-quality datasets are downloadable for users to evaluate and develop computational methods for covalent drug design. CovalentInDB is freely accessible at http://cadd.zju.edu.cn/cidb/.
由于潜在的脱靶效应和毒性问题,传统上,与靶点形成共价键的抑制剂被认为极具冒险性。然而,在过去十年中,随着许多共价抑制剂在临床的验证和批准,新型共价抑制剂的设计和发现引起了越来越多的关注。大量关于共价抑制剂的零散实验数据已经被报道,但是,用于整合共价抑制剂发现的实验信息的资源仍然缺乏。在这项研究中,我们展示了共价抑制剂数据库(CovalentInDB),这是最大的在线数据库,提供了共价抑制剂的结构信息和实验数据。CovalentInDB 包含 4511 种共价抑制剂(包括 68 种已批准的药物),具有 57 种不同的反应性弹头,针对 280 个蛋白质靶标。提供了一些与共价抑制剂结合的蛋白质的晶体结构,以可视化结合部位周围的蛋白-配体相互作用。每个共价抑制剂都用结构、弹头、实验生物活性、物理化学性质等进行了注释。此外,CovalentInDB 为每个抑制剂针对其靶标提供了共价反应机制及其相应的实验验证方法。用户可以下载高质量的数据集,用于评估和开发共价药物设计的计算方法。CovalentInDB 可在 http://cadd.zju.edu.cn/cidb/ 免费获取。